Pharma...This is not death by a thousand cuts..My opinion is that they are speaking with private investors to do a capital raise which I think is paramount. I do not care about dilution at this stage of the game. The roll out and recertifications are going well but we need capital to expand the programs. Problem is when you talk to private investors about raising money if they like the idea they sell stock in anticipation. I care about nothing but sufficient capital to take VBLOC worldwide.
They have training classes for surgeons at the company. They disclosed that on the call.
There have been more than 1 and obviously there is demand. Also I stand to correct myself. Surgeon pal was going to try to get into a class. He is a shareholder. The classes and the webinairs and especially the centers of excellence should be disclosed on the web site. It is not insider information and it is not that difficult. As I have said in the past the IR/R at the company is severly deficient.
Please I am not an employee just a shareholder that speaks to the company. I know nothing more than you but the management understands where they are and what they have to do.
You act very childish. What were you expecting. I am very disappointed they did not raise as much capital and they know capital is vital. They are in the process of retraining former surgeons who by the way have not done the procedure for three years. It is a day or two for each but the centers were nationwide. I expect procedures to be started in April and the company has given no indication of that time.
Curious...Why would you say " they are getting shut out on third party financing." The company has nothing to do with the credit worthiness of a patient. There are numerous companies that are in that business and ETRM's credit has nothing to do with it.
Try another specious argument please. That one was quite rediculous.
Got a call from a good pal who said the most recent edition of Medscape had an article about obesity
" The Shocking Numbers and New Treatment."
Who is the first treatment they picture? VBLOC...Take a look and it is a great website and it is free.
Sentiment: Strong Buy
We have to assume there are a lot of moving parts at the company now and that may be the reason we hear very little in terms of demand, insurance and capital. The thing that strikes me is are they seeing a level of demand that is changing their thinking about how they can satisfy the interest. New companies have this problem and that is why the capital base has to be strong. I think they know that. A lot of the current shareholders have to take a longer term view. Hey, I am not happy about the share price and we have to get the company to let the market know how they see demand and how they plan to address it.
But the more I see these articles like the Medscape one today you have to know they are being contacted by a great deal of professionals who know what we have. And you have to realize Medscape came to ETRM which is meaningful in itself.
Just a matter of time to me, but it is really wearing on a lot of us.Oh, and obesity is not going away any time soon.
I have urged the company to put the centers on the web site. If say the Mayo is a center. But I think the retraining will occur first and then the centers will be listed. The surgeon classes should also be put on the site so as to make that entry easier. We have to remember the last surgeries were actually done 3 years ago. By May 1 we should see a list of centers.
I also like the fact that Brad Hancock was the spokeman in the press release.
Pharma, I think news flow will pick up. There will be more Medscape type relases and I think the insurance problem will be addressed soon. Not a provider expert. Would some providers offer 50% reimbursementmin some cases??
It is always good to have debt and preferred authorization. Straight preferred is non-diutive and at these levels of interest rates saleable even for a credit as weak as SYMX. They could do a convert also.
VCU was one of the clinical sites and now they have been retrained. Mayo is in the process of retraining.
My son lives in Richmond and knows all the docs. I will send him on a recon mission. But the company should put this on their website so people do not have to keep calling. Someone email that dunce IR person and suggest it.
And someone #$%$ on that small finance company we made a deal with??? They are young and aggressive and will be an asset for ETRM.
Personally I doubt they could sell anything right now. This company has promised a lot and has delivered very little. The price of energy collapse and the possible increase in LNG availability makes it tough. Rigdon needs an infusion of capital soon to show someone has interest.
Someone decided on low volume with tomorrow a holiday to sell the stock down?
Seems the investors they are consulting about capital want to steal it....
The bane of small under capitalized companies....
Small stocks with low dollar prices are prey for a lot of boilershops...High risk but they shake trees and scare the schitte out of small investors and this is the result. When they know they have to finance it can get merciless but I have seen this before. With the management and classy institutions owning a lot of stock they will raise the funds..I just with they did it last year...
At the current price there are no options or warrants that have any value. By my count that is about 16 Million shares. The recent award to management is even under water. Ergo, what you see is the value of our company.
To date we have no idea of the progress being made on the device. We have no idea of the potential transactions being negotiated. We know there are approved docs who can do the procedure now. We know the centers that were involved in the trial were world class. We know obesity has to be the #1 killer in the world. We know they have errred by failing to raise capital. The could not have raised anything before approval but failed to sell enouigh of the ATM. They are being poorly advised by their bankers and we know the Metronics and Cyberonics vultures could be circling. I believe they erred in their pricing strategy. With a CTP code and FDA approval reimbursement from private insurers could be achieved. The market gives us no value for our technology and patents. Why there has not been a deal with GSK or another pharma company is difficult for me to understand. The device has been approved over seas and we know we can't market it there at all because we have no capital. Potential partners are looking but they want to see about the U.S. roll out. We will get our answers to a lot of these questions soon. Friday was a terrible manipulation but did not achieve the sales by owners.
The ball is in management's court. These are smart people but a bit naive when it comes to the market. Gpoing to be a fun stock until May 15th. Suggest you grab some Maalox!
Just my opinion and respect yours. I have made my feelings known to the company. We know only what outsiders find, nothing ever confirmed by the company. They will soon enough.
FYI..That Richmond Va bariatric surgeon who is doing VBLOC procedures was just voted a Top Doc in town. Told he leads a group of three surgeons.